Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,175 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Real-Life Safety and Effectiveness of Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis.
Burgel PR, Munck A, Durieu I, Chiron R, Mely L, Prevotat A, Murris-Espin M, Porzio M, Abely M, Reix P, Marguet C, Macey J, Sermet-Gaudelus I, Corvol H, Bui S, Lemonnier L, Dehillotte C, Da Silva J, Paillasseur JL, Hubert D; French Cystic Fibrosis Reference Network Study Group. Burgel PR, et al. Among authors: da silva j. Am J Respir Crit Care Med. 2020 Jan 15;201(2):188-197. doi: 10.1164/rccm.201906-1227OC. Am J Respir Crit Care Med. 2020. PMID: 31601120
Rapid Improvement after Starting Elexacaftor-Tezacaftor-Ivacaftor in Patients with Cystic Fibrosis and Advanced Pulmonary Disease.
Burgel PR, Durieu I, Chiron R, Ramel S, Danner-Boucher I, Prevotat A, Grenet D, Marguet C, Reynaud-Gaubert M, Macey J, Mely L, Fanton A, Quetant S, Lemonnier L, Paillasseur JL, Da Silva J, Martin C; French Cystic Fibrosis Reference Network Study Group. Burgel PR, et al. Among authors: da silva j. Am J Respir Crit Care Med. 2021 Jul 1;204(1):64-73. doi: 10.1164/rccm.202011-4153OC. Am J Respir Crit Care Med. 2021. PMID: 33600738
Real-world assessment of LCI following lumacaftor-ivacaftor initiation in adolescents and adults with cystic fibrosis.
Reix P, Tatopoulos A, Ioan I, Le Bourgeois M, Bui S, Choukroun ML, Bessaci-Kabouya K, Gerardin M, Bokov P, Da Silva J, Paillasseur JL, Burgel PR; French Cystic Fibrosis Reference Network study group. Reix P, et al. Among authors: da silva j. J Cyst Fibros. 2022 Jan;21(1):155-159. doi: 10.1016/j.jcf.2021.06.002. Epub 2021 Jun 26. J Cyst Fibros. 2022. PMID: 34183285 Free article.
Using chest computed tomography and unsupervised machine learning for predicting and evaluating response to lumacaftor-ivacaftor in people with cystic fibrosis.
Campredon A, Battistella E, Martin C, Durieu I, Mely L, Marguet C, Belleguic C, Murris-Espin M, Chiron R, Fanton A, Bui S, Reynaud-Gaubert M, Reix P, Hoang-Thi TN, Vakalopoulou M, Revel MP, Da Silva J, Burgel PR, Chassagnon G; Participating investigators in the French CF reference network study group:; Mounard J, Poulet C, Rames Amiens C, Person C, Troussier F, Urban Angers T, Dalphin ML, Dalphin JC, Pernet D, Richaud-Thiriez Besançon B, Bui S, Fayon M, Macey-Caro Bordeaux J, Campbell K, Laurans Caen M, Borderon C, Heraud MC, Labbé A, Montcouquiol Clermont-Ferrand S, Bassinet L, Remus Créteil N, Fanton A, Houzel-Charavel A, Huet F, Perez-Martin Dijon S, Boldron-Ghaddar A, Scalbert Dunkerque M, Mely Giens L, Camara B, Llerena C, Pin I, Quétant Grenoble S, Cottereau A, Deschildre A, Gicquello A, Perez T, Stervinou-Wemeau L, Thumerelle C, Wallaert B, Wizla Lille N, Languepin J, Ménétrey C, Dupuy-Grasset Limoges M, Bazus L, Buchs C, Jubin V, Werck-Gallois MC, Mainguy C, Perrin T, Reix P, Toutain-Rigolet Lyon Pédiatrie A, Durieu I, Durupt S, Reynaud Q, Nove-Josserand Lyon Adultes R, Baravalle-Einaudi M, Coltey B, Dufeu N, Dubus JC, Stremler Marseille N, Caimmi D, Chiron Montpell… See abstract for full author list ➔ Campredon A, et al. Among authors: da silva j. Eur Respir J. 2022 Jun 16;59(6):2101344. doi: 10.1183/13993003.01344-2021. Print 2022 Jun. Eur Respir J. 2022. PMID: 34795038
Sustained effectiveness of elexacaftor-tezacaftor-ivacaftor in lung transplant candidates with cystic fibrosis.
Martin C, Reynaud-Gaubert M, Hamidfar R, Durieu I, Murris-Espin M, Danner-Boucher I, Chiron R, Leroy S, Douvry B, Grenet D, Mely L, Ramel S, Montcouquiol S, Lemonnier L, Burnet E, Paillasseur JL, Da Silva J, Burgel PR. Martin C, et al. Among authors: da silva j. J Cyst Fibros. 2022 May;21(3):489-496. doi: 10.1016/j.jcf.2022.01.012. Epub 2022 Feb 2. J Cyst Fibros. 2022. PMID: 35123901 Free article.
Specific circulating neutrophils subsets are present in clinically stable adults with cystic fibrosis and are further modulated by pulmonary exacerbations.
Martin C, Dhôte T, Ladjemi MZ, Andrieu M, Many S, Karunanithy V, Pène F, Da Silva J, Burgel PR, Witko-Sarsat V. Martin C, et al. Among authors: da silva j. Front Immunol. 2022 Sep 29;13:1012310. doi: 10.3389/fimmu.2022.1012310. eCollection 2022. Front Immunol. 2022. PMID: 36248793 Free PMC article.
Normalisation of circulating neutrophil counts after 12 months of elexacaftor-tezacaftor-ivacaftor in patients with advanced cystic fibrosis.
Dhote T, Martin C, Regard L, Pesenti L, Kanaan R, Carlier N, Honoré I, Da Silva J, Witko-Sarsat V, Burgel PR. Dhote T, et al. Among authors: da silva j. Eur Respir J. 2023 Jan 6;61(1):2202096. doi: 10.1183/13993003.02096-2022. Print 2023 Jan. Eur Respir J. 2023. PMID: 36455960 Free article. No abstract available.
CFTR Modulators: Current Status and Evolving Knowledge.
Regard L, Martin C, Da Silva J, Burgel PR. Regard L, et al. Among authors: da silva j. Semin Respir Crit Care Med. 2023 Apr;44(2):186-195. doi: 10.1055/s-0042-1758851. Epub 2022 Dec 19. Semin Respir Crit Care Med. 2023. PMID: 36535667 Free article.
4,175 results